Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

Cancer research·2026
Same author

A regulatory circuitry driving a noradrenergic to mesenchymal transition highlights YAP/TAZ as critical players in neuroblastoma plasticity.

Cell reports·2026
Same author

Magnetic bioprinting: shaping initial tissue geometry and probing tissue mechanics.

Biofabrication·2026
Same author

From degradation to (re)magnetization: magnetic reprogramming of maghemite (Massart), magnetite, cobalt ferrite and ferrihydrite nanoparticles by human stem cells.

Nanoscale·2026
Same author

Merging Biological and Synthetic Nanoplatforms: Magnetic Engineering of Extracellular Vesicles via Liposome Fusion.

Nano letters·2026
Same author

Macrophages restrict tumor immune infiltration by controlling collagen topography.

Science immunology·2026

Related Experiment Video

Updated: Jan 18, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.0K

Label-Free Machine Learning Prediction of Chemotherapy on Tumor Spheroids Using a Microfluidics Droplet Platform.

Caroline Parent1, Hasti Honari1, Tiziana Tocci1

  • 1CNRS UMR168 Laboratoire Physique des Cellules et Cancer Institut Curie PSL Research University 26 rue d'Ulm 75 005 Paris France.

Small Science
|September 8, 2025
PubMed
Summary

This study introduces a novel label-free platform using microfluidics and machine learning to quickly assess anticancer drug effectiveness in 3D cell models. It accurately predicts treatment response, enabling efficient drug screening.

Keywords:
droplet microfluidicsdrug testinglabel‐freemachine learningtumor spheroids

More Related Videos

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

9.1K
Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

9.4K

Related Experiment Videos

Last Updated: Jan 18, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

Published on: November 20, 2011

12.0K
Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice
11:34

Modeling Ovarian Cancer Multicellular Spheroid Behavior in a Dynamic 3D Peritoneal Microdevice

Published on: February 18, 2017

9.1K
Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing
09:58

Robotic Production of Cancer Cell Spheroids with an Aqueous Two-phase System for Drug Testing

Published on: April 23, 2015

9.4K

Area of Science:

  • Biotechnology
  • Cancer Research
  • Microfluidics

Background:

  • Evaluating anticancer drug efficacy traditionally requires extensive cell cultures and biochemical assays.
  • 3D cell models, like spheroids, better mimic in vivo tumor environments but pose analytical challenges.
  • Rapid and accurate assessment of treatment response in 3D models is crucial for effective drug discovery.

Purpose of the Study:

  • To develop an integrated, label-free platform for rapid evaluation of anticancer treatment effects in 3D spheroid models.
  • To combine microfluidics, morphological analysis, and machine learning for high-throughput drug screening.
  • To establish a scalable and interpretable method for assessing drug efficacy and determining half maximal inhibitory concentration (IC50) values.

Main Methods:

  • Utilized a droplet-based microfluidic platform for spheroid formation and single-spheroid drug application.
  • Employed label-free morphological analysis to extract spheroid features (size, color intensity).
  • Applied machine learning (neural network) trained on morphological data to classify spheroid viability, benchmarked against metabolic assays.

Main Results:

  • The platform accurately predicted spheroid viability and generated dose-response curves, yielding IC50 values comparable to traditional assays.
  • A machine learning model trained on cell line data demonstrated adaptability by successfully classifying patient-derived xenograft (PDX) spheroids.
  • The label-free, machine learning approach required smaller training datasets and offered greater interpretability than convolutional neural network methods.

Conclusions:

  • The developed integrated platform is a scalable, efficient, and dynamic tool for anticancer drug screening.
  • Label-free morphological analysis combined with machine learning provides a robust and interpretable method for assessing drug response in 3D models.
  • This approach reduces cell requirements and enhances classification quality, accelerating the drug discovery pipeline.